110 results
In a cohort of people after a minor stroke, we aim to investigate whether aforementioned balance tests are sensitive enough to detect subtle balance impairments. Secondly, we will investigate whether fall rates differ between people after a minor…
To investigate the feasibility of a 10 week (maximum) gait training with DFES in rehabilitation starting in the sub-acute phase after stroke and the initial efficacy on the recovery of spatiotemporal parameters, gait kinetics and kinematics,…
This study investigates the safety and tolerability of deferoxamine use in patients with aneurysma subarachnoid hemorrhage.
The primary objective of this study is to compare the changes in neuromuscular control related to reactive and adaptive movements during balance and gait, following Dynamic C-mill Training to conventional physiotherapy. Furthermore, an additional…
The primary objective of the study is:* To evaluate the overall safety and tolerability related to systemic plasminogen activation of single doses of HisproUK (part 1) and sequential administration of tPA and HisproUK (part 2)The secondary…
Primary objective:1) Does individually tailored robotic gait training with the LOPES II result in more reduction of mechanical work during walking and more improvement of gait symmetry than conventional gait training (of similar frequency and…
The aim of ECST-2 is to determine the best current regime for treating patients with asymptomatic and symptomatic carotid stenosis who are at intermediate and lower risk of stroke. Our main hypothesis is that patients who have clinical…
To evaluate whether SAH patients treated by state-of-the-art SAH management with additional ultra-early and short term TXA administration have a significantly higher percentage of favourable outcome after six months (score 0-3 on the Modified Rankin…
to reduce the time between sounding alarm by the patient and start of intravenous thrombolysis and/ or intra-arterial trombectomy in patients with acute ischemic stroke. In a side-line study we will elucidate factors that contributed to a delay in…
- Six weeks of ESM combined with personalized feedback sessions, compared with treatment as usual (TAU), leads to a stronger reduction in fatigue symptoms (primary outcome clinical effectiveness). - This intervention also leads to improvements in…